Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry
BEL, in addition to SoC, controls disease activity, reduces GC use and suppresses organ damage in case of proliferative LN. Earlier BEL induction within 6 weeks may help achieve CRR in treatment-resistant cases without eGFR improvement at 4 weeks after induction therapy.
Authors
- Yasuyuki Todoroki (ORCID: https://orcid.org/0009-0003-4646-592X)
- Yusuke Miyazaki (ORCID: https://orcid.org/0000-0001-5692-3881)
- Yoshiya Tanaka (ORCID: https://orcid.org/0000-0002-0807-7139)
- H. Sakai (ORCID: https://orcid.org/0000-0002-6220-1233)
- Hiroaki Tanaka (ORCID: https://orcid.org/0000-0003-3022-1317)
- Kentaro Hanami
- Naoaki Ohkubo (ORCID: https://orcid.org/0000-0003-2265-4104)
- Masanobu Ueno (ORCID: https://orcid.org/0009-0003-0212-172X)
- Ippei Miyagawa (ORCID: https://orcid.org/0000-0002-9071-145X)
- Shunsuke Fukuyo (ORCID: https://orcid.org/0000-0001-7006-8826)
- Masashi Funada (ORCID: https://orcid.org/0000-0003-2586-246X)
- Satsuki Matsunaga
- Satoshi Kubo (ORCID: https://orcid.org/0000-0001-9693-9263)
- Shingo Nakayamada (ORCID: https://orcid.org/0000-0002-2209-8454)
- Ayako Yamaguchi (ORCID: https://orcid.org/0000-0002-5653-1041)
Institutions
- University of Occupational and Environmental Health Japan (JP)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1093/rheumatology/keae495
- Citations
- 3
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- University of Occupational and Environmental Health